Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Vanguard Short Term Corporate Bond ETF — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Vanguard Short Term Corporate Bond ETF trades at $77.34 (market cap $51.90B). The key difference: Vanguard Short Term Corporate Bond ETF is far larger — about 2.1× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Vanguard Short Term Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Vanguard Short Term Corporate Bond ETF for 52 Days on average.
| RPRX | VCSH | |
|---|---|---|
Market Cap | $25.27B | $51.90B |
Volume | 3,671,183 | 5,450,864 |
Sector | Health | Fixed Income |
52-Week High | $63.96 | $80.20 |
52-Week Low | $35.44 | $77.03 |
Typical Hold Time | 0 Days | 52 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VCSH trades at $77.27 with minimal daily movement (+0.08%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The ETF maintains a competitive 4.5% dividend yield with a short 2.7-year duration, providing stability amid rate uncertainty. Recent news highlights institutional positioning shifts and comparisons with peer funds.
VCSH offers conservative investors exposure to high-quality short-term corporate bonds with minimal interest rate risk. The primary opportunity lies in its higher yield compared to Treasury alternatives, though credit spreads remain tight. Key risks include potential credit deterioration and limited price appreciation given current market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
